Researcher from Peking University Cancer Hospital and Institute Publishes Findings in Solid Cancer (Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors).

Předmět:	FIBROBLAST growth factor receptors MEDICAL genetics FLUORESCENCE in situ hybridization CANCER hospitals COENZYMES
Zdroj:	Cancer Weekly; 10/15/2024, p1088-1088, 1p
Abstrakt:	A recent report published by researchers from Peking University Cancer Hospital and Institute discusses the importance of the fibroblast growth factor receptor (FGFR) in cancer development. The report highlights that mutations in the FGFR gene can disrupt various biological processes and lead to cancer. The researchers emphasize the clinical benefits of targeting these mutations with small molecule drugs or antibodies. They also provide an expert consensus on the diagnosis and treatment of FGFR gene-altered solid tumors, aiming to standardize the process and facilitate the practical application of FGFR inhibitors in clinical practice. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu